Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Sales

Burning Rock Biotech (BNR) FCF Margin: 2020-2024

Historic FCF Margin for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to 18.94%.

  • Burning Rock Biotech's FCF Margin rose 9319.00% to 12.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.66%, marking a year-over-year increase of 2885.00%. This contributed to the annual value of 18.94% for FY2024, which is 3016.00% up from last year.
  • According to the latest figures from FY2024, Burning Rock Biotech's FCF Margin is 18.94%, which was up 61.43% from 49.10% recorded in FY2023.
  • In the past 5 years, Burning Rock Biotech's FCF Margin registered a high of 18.94% during FY2024, and its lowest value of 134.33% during FY2021.
  • Its 3-year average for FCF Margin is 53.39%, with a median of 49.10% in 2023.
  • As far as peak fluctuations go, Burning Rock Biotech's FCF Margin plummeted by 10,320bps in 2021, and later skyrocketed by 4,302bps in 2023.
  • Over the past 5 years, Burning Rock Biotech's FCF Margin (MRY) stood at 31.13% in 2020, then crashed by 332bps to 134.33% in 2021, then surged by 31bps to 92.12% in 2022, then surged by 47bps to 49.10% in 2023, then skyrocketed by 61bps to 18.94% in 2024.
  • Its last three reported values are 18.94% in FY2024, 49.10% for FY2023, and 92.12% during FY2022.